Pioneers Of Medicine Codexery

Leland H. Hartwell

Nobel laureate who discovered cell cycle control genes in yeast.

Leland H. Hartwell

Leland H. Hartwell shared the 2001 Nobel Prize in Physiology or Medicine for his discoveries regarding the mechanisms that control cell division. After retiring from leading the Fred Hutchinson Cancer Research Center in 2010, Hartwell left to join Arizona State University.

known_for
Discovery of cell division cycle (CDC) genes and cell cycle checkpoints in yeast

Verified Timeline

1975197619902001200420102022

Lore & Background

Leland H. Hartwell received the 2001 Nobel Prize in Physiology or Medicine for his discoveries regarding the mechanisms that control cell division. He served as president and director of the Fred Hutchinson Cancer Research Center, retiring in 2010. After retiring, Hartwell left to join Arizona State University.

Reader's Guide

He was the third president and director of the Fred Hutchinson Cancer Research Center, serving until 2010. Following his retirement from the center, he moved to Arizona State University.

Did You Know?

Nobel Recognition for Cell Division Research

Leland H. Hartwell stands as one of the most distinguished scientists associated with the Fred Hutchinson Cancer Center in Seattle, Washington. In 2001, he was awarded the Nobel Prize in Physiology or Medicine, an honor that recognized his groundbreaking discoveries concerning the mechanisms that govern cell division. This achievement placed him among the select group of researchers whose work has shaped the fundamental understanding of how living cells replicate and grow. At the time of his recognition, Hartwell was employed at the center, which had been operating in the Pacific Northwest since 1975. His work on cell division control mechanisms represented a significant contribution to the basic research mission the center had pursued since receiving its NCI-designated Comprehensive Cancer Center status in 1976. The Nobel Prize cemented his legacy as a scientist whose discoveries touched the very foundations of cellular biology, a field intimately connected to the broader understanding and treatment of cancer.

Serving as the Center's Third President

Hartwell's connection to the Fred Hutchinson Cancer Center extended well beyond his laboratory research. He served as the institution's third President, a leadership role that placed him at the helm of one of the nation's premier cancer research institutes. His tenure as president spanned a period during which the center continued to grow and evolve, having been established in 1975 and designated a Comprehensive Cancer Center by the NCI in 1976. His leadership came after the center had navigated significant challenges, including the 2001 Seattle Times investigation into research ethics and the subsequent adoption of new conflict-of-interest rules. Hartwell retired from his presidential role in 2010, at which point Lawrence Corey was appointed as the fourth President to continue guiding the institute. The succession of leadership at the center reflected its ongoing commitment to both research excellence and institutional stewardship over its decades of operation in Seattle.

One of Three Nobel Laureates at the Center

The Fred Hutchinson Cancer Center in Seattle has been home to an extraordinary concentration of scientific talent, and Leland H. Hartwell was one of three individuals employed there who received the Nobel Prize in Physiology or Medicine. His 2001 award for work on cell division mechanisms joined the honors of Linda B. Buck, who in 2004 was recognized for her elucidation of the olfactory system, and E. Donnall Thomas, who received the prize in 1990 for his pioneering contributions to bone-marrow transplantation. Thomas held a particularly close connection to the institution, having been its co-founder. The fact that three Nobel laureates were associated with a single cancer research center in the Pacific Northwest underscored the depth of scientific achievement the institute had cultivated since its origins in 1975. Hartwell's presence among this distinguished trio reflected the center's role as a magnet for researchers working at the frontiers of biomedical science.

A New Chapter at Arizona State University

Following his retirement from leading the Fred Hutchinson Cancer Center in 2010, Leland H. Hartwell embarked on a new professional chapter by joining Arizona State University. His departure in 2010 was followed by the appointment of Lawrence Corey as the center's fourth President, signaling a transition in leadership at the institution. This transition came at a time when the center was continuing to expand its operations and influence, eventually merging with the Seattle Cancer Care Alliance in 2022 to form the unified Fred Hutchinson Cancer Center.

Frequently Asked Questions

Who is Leland H. Hartwell?

Leland Harrison 'Lee' Hartwell is an American biologist born on October 30, 1939, best known for his groundbreaking work on how cells regulate their division. He also served as president and director of the Fred Hutchinson Cancer Research Center in Seattle.

What discovery made Leland H. Hartwell famous?

Hartwell identified the fundamental role of checkpoints in controlling the cell cycle and characterized key CDC genes, including CDC28, which governs the initiation of the cycle. His work revealed how protein molecules act as molecular switches to keep cell division in check.

What organism did Leland H. Hartwell use in his research?

He conducted his landmark cell-cycle studies in yeast, a simple single-celled organism that proved ideal for uncovering the conserved mechanisms of division control.

Who shared the 2001 Nobel Prize in Physiology or Medicine with Leland H. Hartwell?

Paul Nurse and Tim Hunt joined Hartwell as co-laureates, all three being recognized for their discoveries of protein molecules that control cell division.

Why is Leland H. Hartwell important to modern medicine?

His identification of cell-cycle checkpoints and CDC genes laid the groundwork for understanding how uncontrolled division leads to cancer. This knowledge directly informed the development of targeted cancer therapies that exploit those same regulatory pathways.

More in Pioneers Of Medicine 25-29

Related in Pioneers Of Medicine

Links follow this subject's own source article.

Elsewhere in the Pioneers Of Medicine universe

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →